CoChat

Relationship of vascular risk to the progression of Alzheimer disease

Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J., Livingston, G. · 2006 · Neurology
Cited by 126

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To test the hypothesis that patients with Alzheimer disease (AD) who have vascular risk factors have a worse prognosis over 18 months vs those without such risk factors. METHODS: A sample of 224 people with AD and their caregivers were recruited purposively to be representative of people with dementia in terms of cognition, sex, and living situations in a longitudinal study of AD. Standardized instruments measuring cognition, functional status, and neuropsychiatric symptoms were used to collect data. Physical examination and relevant blood tests were performed. RESULT: There was no difference in rate of deterioration between people with and without vascular risk factors, except in those who had a cerebrovascular accident (CVA) during the 18-month follow-up (p < 0.001). We considered possible confounders of outcome: sex, age, years of education, severity of dementia, depression, taking cholinesterase inhibitors (AChEIs), and whether those with vascular risk factors were more likely to die, but the results remained unchanged. Stopping AChEIs during the study was associated with cognitive and functional decline (p < 0.001). CONCLUSIONS: Vascular risk factors as measured clinically and biochemically do not significantly increase deterioration at 18 months in people with Alzheimer disease who have a low burden of cerebrovascular risk factors. However, cerebrovascular events are associated with more rapid decline. Vascular risk factors may contribute to the expression of Alzheimer disease initially but are not part of the underlying etiologic process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000240129.46080.53

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 27

  1. 10.1097/00002093-199912003-00017 · DOI · Paper page
  2. 10.1097/00041433-200404000-00005 · DOI
  3. Breteler MM, Bots ML, Ott A, Hofman A. Risk factors for vascular disease and dementia. Haemostasis 1998;28:167–173.
  4. 10.1016/S0140-6736(96)09328-2 · DOI · Paper page
  5. 10.1192/bjp.177.1.66 · DOI · Paper page
  6. 10.1136/bmj.38446.466238.E0 · DOI · Paper page
  7. Bugiani O. AB-related cerebral amyloid angiopathy. Neurol Sci 2004;24:S1–S2.
  8. 10.1212/WNL.58.10.1471 · DOI · Paper page
  9. 10.1073/pnas.94.11.5923 · DOI · Paper page
  10. 10.1212/01.WNL.0000158476.74580.A8 · DOI
  11. 10.1016/0021-9681(74)90013-7 · DOI · Paper page
  12. Regan C, Katona C, Walker Z, Livingston G. Relationship of exercise and other risk factors to depression of Alzheimer’s disease: the LASER-AD study. Int J Geriatr Psychiatry 2005;20:261–268.
  13. Fratglioni L. Health economics of dementia. Epidemiology 1998;2:13–31.
  14. 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders fourth edition.Washington DC: American Psychiatric Association 1994;138–142.
  16. 10.1212/WNL.34.7.939 · DOI · Paper page
  17. 10.2337/diacare.25.2.275 · DOI · Paper page
  18. 10.1037/1040-3590.2.3.298 · doi:10.1037/1040-3590.2.3.298 · Paper page
  19. Mohs RC, Rosen WG, Davis KL. The Alzheimer’s Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19:448–450.
  20. Mohs RC, Cohen L. Alzheimer’s Disease Assessment Scale (ADAS). Psychopharmacol Bull 1988;24:627–628.
  21. 10.1097/00002093-199700112-00005 · DOI · Paper page
  22. 10.1093/ageing/32.2.200 · DOI · Paper page
  23. 10.1056/NEJM199301213280301 · DOI · Paper page
  24. 10.1093/oxfordjournals.aje.a116417 · DOI · Paper page
  25. 10.1136/jnnp.65.2.143 · DOI · Paper page
  26. 10.1136/jnnp.2003.030189 · DOI · Paper page
  27. 10.1159/000026149 · DOI · Paper page

Cited by

See all 126

Metadata

Authors
Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J., & Livingston, G.
Venue
Neurology
Published
2006-10-24
Volume
67
Issue
8
Pages
1357-1362
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2107917334
Cited by
126
References
13
FWCI
5.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationship of vascular risk to the progression of Alzheimer disease. https://app.cochat.ai/papers/10.1212/01.wnl.0000240129.46080.53
The paper
Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J., & Livingston, G. (2006). Relationship of vascular risk to the progression of Alzheimer disease. Neurology. https://doi.org/10.1212/01.wnl.0000240129.46080.53

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.